from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2275/-

LFCtreatmentdescriptionclass of inhibitor

0.153

Amikacinug/mL Amikacintranslation

1.517

Cap5-10ug/mL Capreomycintranslation

1.605

Rox10-50 ug/mL Roxithromycintranslation

0.556

SM2-5 ug/mL Streptomycintranslation

0.113

Tet5-10 ug/mL Tetracyclinetranslation

0.120

Rif0.2-5ug/mL Rifampicintranscription

0.430

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.566

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.826

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.195

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.488

Clofazimine10-13 ug/mL Clofaziminerespiration

0.216

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.890

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.307

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.573

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.331

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.364

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.084

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.966

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.063

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.186

KCN5-20 ug/mL Potassium cyaniderespiration

-0.110

NaN30.2-2 mM Sodium aziderespiration

0.924

Nigericin50 uM Nigericinrespiration

-0.270

TRC10-150 ug/mL Triclosanrespiration

-1.565

TRZ10-25 ug/mL Thioridazinerespiration

0.492

Valinomycin0.5-10 uM Valinomycinrespiration

1.504

ZnSO42 mM ZnSO4respiration

-0.370

menadione6-10 ug/mL Menadionerespiration

-0.546

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.787

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.195

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.815

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.233

NRP_1Non-replicating persistence stage 1dosRassociated

1.068

Amp0.2mg/mL AmpicillincellWall

0.211

Cephalexin20-100 ug/mL CephalexincellWall

0.746

Cerulenin0.32-5 ug/mL CerulenincellWall

0.998

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.264

EMB10-20 ug/mL EthambutolcellWall

0.516

Eta12-40 ug/mL EthionamidecellWall

-0.485

INH0.2-0.4 ug/mL IsoniazidcellWall

0.475

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.319

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.063

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.153

BZA0.12 mg/mL BenzamidearomaticAmides

0.081

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.201

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.226

H2O24 mM hydrogen peroxideDNAdamaging

0.629

Levo10 ug/mL LevofloxacinDNAdamaging

0.790

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.424

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.019

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.233

UVUV-irradiationDNAdamaging

-0.891

ARP41-4 ug/mL Antitubercular compound ARP4?

0.231

Antimycin12.5-50 ug/mL Antimycin A?

0.806

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.055

PA_110-50 ug/mL Antitubercular compound PA-1?

0.103

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.103

PA8240.2-2 ug/mL PA-824?

-1.147

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.020

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.474

Verapamil50 uM Verapamil?

0.954

mercaptoethanol2 mM 2-Mercaptoethanol?

0.806

methoxatin10-20 ug/mL Methoxatin?